Metastasis (Lecture 2)

Slide 1 · Metastasis to the liver

Metastatic malignancy involving the liver

Gross patterns • dissemination • colonization • diagnostic reasoning

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Recognize the common primaries and gross patterns of hepatic metastases.

Explain how vascular anatomy and metastatic biology direct liver involvement.

Separate local invasion, dissemination, extravasation, and colonization.

Use morphology and clinical context to frame the differential diagnosis.

Slide 3 · Metastatic lesions dominate hepatic malignancy

Secondary involvement

Secondary cancer deposits are far more common than primary liver neoplasia.

A liver mass therefore requires consideration of an extrahepatic origin.

Primary hepatic neoplasia

Hepatocellular carcinoma is the dominant primary hepatic malignancy.

Cholangiocarcinoma is another important primary epithelial cancer.

Slide 4 · Common primary sources of hepatic metastases

Primary tumor

Teaching connection

Colorectal carcinoma

Portal venous drainage provides a direct route.

Breast carcinoma

Systemic dissemination may involve the liver.

Lung carcinoma

Systemic spread can seed hepatic tissue.

Pancreatic carcinoma

A frequent source of secondary liver lesions.

Slide 5 · Virtually any malignant primary can reach the liver

The common source list is not exhaustive.

The pattern of spread depends on vascular access, tissue homing, and colonization.

A hepatic metastasis may be recognized before its primary site is established.

Clinical history and pathology must be integrated rather than presumed.

Slide 6 · Why the liver is a frequent metastatic target

Extensive venous inflow

Sinusoidal capillary bed

Tumor-cell arrest

Surviving cells may colonize

Slide 7 · Colorectal primaries: A portal venous route

Portal drainage

Intestinal / pancreatic venous return

Liver microvasculature

First downstream filter for many abdominal primaries

Hepatic deposit

Successful arrest followed by colonization

Slide 8 · Portal drainage explains—but does not guarantee—spread

Colonic tumors frequently seed the liver because it is downstream.

Anatomic delivery creates opportunities for arrest, not inevitable metastatic growth.

Many circulating tumor cells fail to form secondary tumors.

Host tissue compatibility is needed for productive colonization.

Slide 9 · Hepatic spread can arise from systemic primaries

Extrahepatic malignancy

Vascular dissemination

Delivery to liver

Homing and colonization

Slide 10 · Anatomic routing and organ tropism act together

Vascular opportunity

Venous drainage influences the first capillary bed reached.

The liver filters blood arriving via the portal system.

Biologic selectivity

Tumor-cell adhesion and chemokine pathways can favor sites.

Local tissue may or may not support survival and proliferation.

Slide 11 · Multiple hepatic nodules: The typical gross pattern

Conceptual tissue schematic — not a gross specimen

Usual appearance

Many separate tumor nodules distributed through hepatic parenchyma.

Slide 12 · Nodularity reflects separate successful deposits

Circulating tumor cells

Arrest at multiple sites

Local tumor expansion

Multiple nodular masses

Slide 13 · Metastases can replace extensive parenchyma

Conceptual tissue schematic — not a gross specimen

Tumor burden

Expanding nodules may displace or replace broad regions of hepatic tissue.

Slide 14 · Marked hepatomegaly in heavy metastatic burden

Numerous nodules may substantially enlarge the liver.

Normal hepatic parenchyma can be replaced over broad regions.

In exceptional cases, the liver may weigh several kilograms.

These gross changes indicate tumor burden, not a specific primary site.

Slide 15 · A solitary hepatic nodule may also be metastatic

Conceptual tissue schematic — not a gross specimen

Recognized variant

A single metastatic nodule may be present; It cannot be excluded by count alone.

Slide 16 · Multiplicity is informative, not a defining criterion

Multiple nodules

Typical presentation of metastatic involvement.

Supports dissemination when compatible with patient history.

Solitary nodule

Still compatible with metastasis.

Requires a careful differential with a primary liver tumor.

Slide 17 · A liver mass needs a primary-versus-secondary framework

Question

Why it matters

Is cancer documented elsewhere?

Makes hepatic metastasis more plausible.

Is the lesion solitary or multifocal?

Helps characterize the pattern, not definitive etiology.

Is chronic liver disease known?

Provides context for primary HCC.

Does sampled tumor show a tissue lineage?

Histology and IHC may help identify origin.

Slide 18 · Primary hepatic cancers in the differential

Hepatocellular carcinoma

Common primary malignant hepatic neoplasm.

Often associated with chronic liver disease / cirrhosis.

Cholangiocarcinoma

Adenocarcinoma arising from intrahepatic bile ducts.

Typically produces glandular carcinoma in fibrous stroma.

Slide 19 · Metastasis is distinct from contiguous invasion

Local invasion

Cancer extends into neighboring structures.

A prerequisite to distant dissemination in many solid tumors.

Metastasis

Tumor appears at a physically discontinuous site.

Evidence of malignant behavior beyond the primary location.

Slide 20 · Invasion and metastatic competence can diverge

Some cancers invade strongly but rarely metastasize.

Gliomas and basal cell carcinoma as examples.

A tumor must do more than cross its local tissue boundary.

Survival in circulation and growth at a distant site are additional barriers.

Slide 21 · Three pathways of tumor dissemination

Pathway

Typical context

Relation to liver deposits

Bloodstream

Common route for distant organ metastasis

Especially relevant to hepatic parenchymal lesions

Lymphatics

Frequent early carcinoma dissemination

Often precedes or accompanies broader spread

Body cavity seeding

Free surface dissemination

Different pattern from parenchymal hematogenous nodules

Slide 22 · Hematogenous dissemination often uses small veins

Small veins have walls easier to penetrate than arteries.

Vessel invasion at the primary tumor is associated with distant spread.

Tumor emboli can then encounter downstream capillary beds.

Hematogenous spread is characteristic of sarcomas and occurs in carcinomas.

Slide 23 · Liver and lung are major vascular filters

Liver

Portal venous inflow captures tumor cells from many abdominal organs.

A common site for hematogenous secondary tumors.

Lung

Systemic venous return reaches pulmonary capillaries.

Another common destination for blood-borne dissemination.

Slide 24 · Vascular arrival does not prove colonization

Tumor cells enter blood

Many cells are eliminated

A minority arrests

Still fewer form growing metastases

Slide 25 · Metastasis is a multistep biological cascade

ECM invasion

Intravasation

Circulating survival

Arrest and extravasation

Colonization

Slide 26 · The two phases of the metastatic cascade

Phase 1: Local escape

Lose cell–cell cohesion.

Remodel and traverse extracellular matrix.

Enter the vascular compartment.

Phase 2: Distant establishment

Survive circulatory challenges.

Home, arrest and leave the vessel.

Persist and grow in the target tissue.

Slide 27 · Carcinoma cells must cross extracellular barriers

Epithelial basement membrane

Interstitial extracellular matrix

Vascular basement membrane

Circulating compartment

Slide 28 · Four coordinated steps drive ECM invasion

Reduced cell cohesion

ECM degradation

New ECM attachment

Active cell migration

Slide 29 · Loss of E-cadherin favors tumor-cell dissociation

Intact epithelial adhesion

E-cadherin maintains cell–cell contacts.

Coherent architecture restrains individual movement.

Invasive transition

Loss of adhesion facilitates separation.

Disengaged malignant cells can begin invasion.

Slide 30 · Epithelial–mesenchymal transition modifies migration

Change

Function in the proposed model

Reduced E-cadherin

Weaker epithelial cell–cell adhesion

Increased vimentin / smooth muscle actin

More mesenchymal marker expression

SNAIL and TWIST activity

Transcriptional control of EMT programs

Promigratory phenotype

Contributes to invasive competence

Slide 31 · Proteases permit passage through tissue matrix

Tumor / stromal protease release

Basement membrane remodeling

Interstitial matrix cleavage

Route for cell invasion

Slide 32 · Matrix metalloproteinases have dual consequences

Physical remodeling

Degrade structural components of basement membrane and stroma.

Open routes for cell movement.

Biologic signaling

Liberate matrix-sequestered factors.

Generate cleavage fragments affecting motility and angiogenesis.

Slide 33 · MMP9 links matrix digestion with angiogenic signals

MMP9 can cleave type IV collagen in basement membranes.

Proteolysis can release VEGF from extracellular matrix stores.

Generated matrix fragments may stimulate migration and angiogenesis.

This demonstrates why invasion is more than mechanical tissue destruction.

Slide 34 · Integrins retune tumor attachment to ECM

Integrins connect cells to extracellular proteins and signaling systems.

Tumors may alter integrin expression during invasion.

Remodeled matrix can expose new receptor-binding sites.

Attachment changes contribute to movement and survival outside normal epithelial niches.

Slide 35 · Resistance to anoikis enables detached-cell survival

Normal epithelial cell

Loss of appropriate matrix attachment can initiate apoptosis.

This process is termed anoikis.

Malignant cell

Altered integrin signaling may sustain viability after detachment.

This trait helps cells survive displacement from their home tissue.

Slide 36 · Tumor motility depends on actin dynamics

Attach leading edge

Contract actin cytoskeleton

Detach trailing edge

Advance through remodeled ECM

Slide 37 · Cancer-associated stroma supports invasion

Tumor-cell signals

Malignant cells communicate with fibroblasts and inflammatory cells.

Growth factors and chemokines influence migration.

Stromal responses

Stroma can release proteases and growth factors.

Cancer-associated fibroblasts modify ECM production and remodeling.

Slide 38 · Intravasation connects local invasion to dissemination

Cancer infiltrates stroma

Crosses vessel basement membrane

Traverses endothelium

Enters bloodstream

Slide 39 · Circulating tumor cells face multiple hazards

Challenge

Implication

Mechanical shear

Tumor cells can be physically damaged.

Loss of anchorage

Anoikis threatens detached cells.

Innate immune defenses

Host mechanisms can destroy circulating cells.

Adaptive immune defenses

Immune recognition constrains metastatic success.

Slide 40 · Cell clusters and platelets can favor survival

Tumor-cell aggregate

Platelet association

Bloodstream (schematic)

Slide 41 · Tumor emboli may lodge as multicellular aggregates

Collective migration can provide a survival advantage over single cells.

Platelet association may help protect circulating malignant cells.

Fibrin deposition may stabilize tumor emboli.

Arrest in small vascular beds is not identical to successful growth.

Slide 42 · Three determinants govern metastatic destinations

Primary site and drainage

Tumor tissue tropism

Escape from dormancy

Clinically apparent deposit

Slide 43 · Tissue tropism explains exceptions to drainage rules

Example

Favored site / interpretation

Colorectal carcinoma

Liver: Portal drainage is important.

Breast and prostate carcinoma

Bone: Selective organ tropism.

Lung carcinoma

Brain / adrenal spread may occur.

Ocular melanoma

Pronounced liver tropism.

Slide 44 · Adhesion molecules can influence organ homing

Endothelial ligands differ between vascular territories.

Cancer-cell surface adhesion molecules may favor selected organs.

CD44–hyaluronate interactions illustrate tissue-specific adhesion.

Homing is one component, not the whole explanation of metastasis.

Slide 45 · Chemokine signaling contributes to site selection

Cancer cell expresses receptor

Target tissue supplies chemokine

Directed adhesion / trafficking

Potential organ preference

Slide 46 · The seed-and-soil hypothesis explains colonization

Seed: Cancer-cell traits

A disseminated cell needs compatible survival and growth programs.

Adhesion and adaptation vary among cancer types.

Soil: Target-organ milieu

Some host tissues are permissive.

Other well-perfused tissues are comparatively unfavorable.

Slide 47 · Liver sinusoidal endothelium shapes extravasation

Vascular lumen

Surrounding hepatic tissue

Endothelial crossing + matrix passage

Slide 48 · Extravasation is another active invasion event

Vascular arrest

Endothelial transmigration

Crossing basement membrane

Entry into hepatic tissue

Slide 49 · Extravasation recruits adhesion, proteolysis, and signals

Integrins and laminin receptors can contribute to adhesion.

Proteolytic enzymes help traverse local barriers.

Chemokines participate in the process.

Tumor and innate immune cells may provide relevant mediators.

Slide 50 · Colonization requires adaptation to a new tissue

Successful arrival

A cell can arrest and survive temporarily in a new organ.

Some disseminated cells remain microscopic or nonproliferative.

Successful metastasis

A compatible microenvironment permits sustained growth.

Stromal interactions can support expansion and angiogenesis.

Slide 51 · Tumor dormancy separates seeding from outgrowth

Disseminated cancer cell

Long-lived non-growing state

Possible dormancy escape

Clinically evident metastasis

Slide 52 · Tumor–stroma feedback makes metastatic growth possible

Tumor cells can secrete cytokines, growth factors, and ECM molecules.

Resident stromal cells respond and can support the metastatic focus.

Stromal support is organ- and tumor-dependent.

A deposited cell is not equivalent to a self-sustaining secondary tumor.

Slide 53 · Why metastatic biology produces variable liver burden

Biologic level

Potential visible consequence

Vascular arrival

Cells reach the hepatic microvascular bed.

Arrest and extravasation

Small deposits become possible.

Dormancy versus outgrowth

Delayed or absent macroscopic lesion.

Repeated colonization / growth

Solitary or numerous nodules; Large tumor burden.

Slide 54 · Clinical context frames a metastatic liver lesion

Known extrahepatic cancer changes the working differential.

A common source does not establish identity in an individual case.

Multiplicity supports secondary deposits but is not absolute.

The tissue diagnosis must be interpreted together with clinical information.

Slide 55 · Histopathology and lineage studies aid source identification

Morphology

Assess the tumor architecture and differentiation.

Compare with a known primary when material is available.

Immunohistochemistry

Lineage / organ-associated antigens can identify likely origin.

Interpret panels in context; No single stain is universal.

Slide 56 · Organ-associated markers: Illustrative Robbins examples

Marker example

Source identity it may support

Prostate-specific antigen (PSA)

A prostatic primary in the appropriate setting.

Thyroglobulin

Thyroid follicular-cell origin in suitable tumors.

Tissue/organ-specific antigen panels

Investigation of otherwise obscure primary site.

Slide 57 · Pitfall: Primary hepatic malignancy also forms masses

Features raising HCC context

Documented chronic liver disease / cirrhosis.

Primary hepatocellular neoplasm remains plausible.

Features raising metastasis context

Extrahepatic primary malignancy.

Typical multiple nodular hepatic deposits.

Slide 58 · Cholangiocarcinoma is an important primary mimic

Intrahepatic cholangiocarcinoma is a primary biliary epithelial malignancy.

Its glands may be embedded in abundant desmoplastic stroma.

The diagnosis cannot be based solely on the presence of gland-forming malignancy.

Primary site assessment requires clinicopathologic integration.

Slide 59 · Applied case: Colorectal malignancy with liver nodules

A patient with an established colonic carcinoma has several discrete hepatic nodules and an enlarged liver on imaging.

Interpretation task

Which hematogenous route is anatomically favored?

Which gross pattern is described in the hepatic metastasis section?

Does vascular delivery alone explain visible tumor growth?

Slide 60 · Case interpretation: Anatomy plus colonization

Colonic primary

Portal venous delivery

Hepatic arrest

Successful secondary outgrowth

Slide 61 · Applied case: A solitary liver mass

A patient with a previous malignancy develops one hepatic mass. No other hepatic nodules are recognized.

Interpretation task

Does a single lesion exclude metastatic malignancy?

Which primary liver cancers belong in the differential?

How can histology and tissue-lineage studies help?

Slide 62 · Case interpretation: Do not equate solitary with primary

Observation

Reasoned interpretation

Single hepatic nodule

Compatible with either metastasis or primary liver tumor.

Previous extrahepatic cancer

Supports but does not prove metastatic origin.

Cirrhosis / liver-disease history

Relevant context for primary HCC.

Biopsy morphology and lineage

May clarify tissue of origin.

Slide 63 · Integrated model of hepatic metastasis

Malignant primary

Invasion and blood access

Liver homing / extravasation

Colonization and nodules

Slide 64 · Principles to retain

Metastatic cancer in the liver is more frequent than primary hepatic malignancy.

Colon, breast, lung, and pancreas are important—but not exclusive—sources.

Multiple nodules and hepatomegaly are typical; A solitary deposit can occur.

Portal anatomy explains many cases, while tropism and colonization explain selectivity.

Slide 65 · Selected textbook reading

Robbins, Cotran & Kumar: Pathologic Basis of Disease. 11th ed. (2026).

Chapter 18, Liver and Gallbladder: “Metastasis,” printed p. 793.

Chapter 7, Neoplasia: metastatic pathways, invasion, homing and colonization.

See Chapter 7 for the mechanistic basis of hematogenous dissemination.